ANXA1 and central nervous system cancer: The results demonstrated that ANXA1 was overexpressed in gliomas with higher expression in GBM samples than in LGG samples (p < 0.05, Figure 2I), supporting that ANXA1 is correlated with a higher grade of gliomas.